No Data
No Data
jointown pharmaceutical group (600998.SH): Vice Chairman Gong Yihua concurrently serving as General Manager.
Jointown Pharmaceutical Group (600998.SH) announced on October 15 that due to work adjustments, Mr. He Wei, a director and general manager of the company, no longer serves as the general manager. As proposed by the chairman of the board of directors, Mr. He Wei will also take on the roles of vice president and general manager of the South China region. In accordance with the relevant provisions of the Company Law and the company's articles of association, nominated by the chairman of the board and reviewed by the board of directors and the remuneration and assessment committee, the board of directors agreed to appoint Mr. Gong Yihua, the vice chairman, as the company's general manager, and approved the appointment of Mr. Liu Yichang as the company's business director. The term of office for both positions shall commence from the date of this board meeting's approval.
Jointown Pharmaceutical Group (600998.SH): received the Registration Notice from Bank of China Interbank Market Traders Association.
On October 15th, Gelonhui reported that jointown pharmaceutical group (600998.SH) recently received a "Registration Acceptance Notice" with the registration number of "中市协注[2024]ABN118" issued by the National Interbank Funding Center Trade Association (referred to as the 'Trade Association'), accepting the registration of company's asset-backed commercial paper with a registered amount of 2 billion yuan. The registration amount will be valid for 2 years from the date of the notice, underwritten by China Zheshang Bank Limited. The company can issue asset-backed commercial paper in installments and renewals during the valid registration period, with the first issuance to be completed within 6 months after registration.
Private Companies in Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Are Its Biggest Bettors, and Their Bets Paid off as Stock Gained 4.2% Last Week
jointown pharmaceutical group (600998.SH): has repurchased a cumulative 1.10%.
Gelonghui October 8th | jointown pharmaceutical group (600998.SH) announced that, as of September 30, 2024, the company has repurchased a total of 55.4705 million stocks, accounting for 1.10% of the total share capital, with a highest purchase price of 5.18 yuan/stock and a lowest purchase price of 4.42 yuan/stock. The total amount paid is 265.017 million yuan (excluding commissions and fees).
Jointown Pharmaceutical Group (600998.SH): As of August 31, 2024, the company's retail brand Good Pharmacist has reached 25,663 directly-operated and franchised pharmacies.
Guolonghui October 8th | Jointown Pharmaceutical Group (600998.SH) stated on the interactive platform that the company's pharmaceutical new retail and franchise business has made breakthrough progress. As of August 31, 2024, the company's retail brand, Good Pharmacist, has reached 25,663 direct-operated and franchised pharmacies, exceeding the target for 2024. It is expected to reach 30,000 by the end of the year, achieving the layout goal of Good Pharmacist retail pharmacies one year ahead of schedule. Currently, the number of Good Pharmacist retail stores (including franchise stores) has taken the lead in the industry, and has been honored as one of the "Top Ten Pharmaceutical Retail Companies in China with the Highest Sales in 2023".
jointown pharmaceutical group (600998.SH): to privately issue preferred shares for listing transfer.
Jointown Pharmaceutical Group (600998.SH) announced on September 18th that, with the approval of the Shanghai Stock Exchange, the preferred shares issued by the company will be listed for transfer on the Shanghai Stock Exchange Comprehensive Business Platform starting from September 24th, 2024.
No Data
No Data